Analyst Ratings For NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB)
Today, B. Riley lowered its price target on NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB) to per share.
Some recent analyst ratings include
- 4/13/2018-Chardan Capital was Downgraded by analysts at Chardan Capital from a “Buy ➝ Neutral” rating to a “” rating. They now have a $35.00 ➝ $50.00 price target on the stock.
- 8/19/2016-William Blair initiated coverage with a Market Perform ➝ Outperform rating.
Recent Insider Trading Activity For NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB)
NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB) has insider ownership of 18.20% and institutional ownership of 77.28%.
- On 5/1/2018 William R Ringo, Director, sold 1,000 with an average share price of $43.06 per share and the total transaction amounting to $43,060.00.
- On 4/2/2018 William R Ringo, Director, sold 1,000 with an average share price of $49.32 per share and the total transaction amounting to $49,320.00.
- On 3/1/2018 William R Ringo, Director, sold 1,000 with an average share price of $56.37 per share and the total transaction amounting to $56,370.00.
- On 2/1/2018 William R Ringo, Director, sold 1,000 with an average share price of $46.86 per share and the total transaction amounting to $46,860.00.
- On 1/2/2018 William R Ringo, Director, sold 1,000 with an average share price of $45.04 per share and the total transaction amounting to $45,040.00.
- On 12/1/2017 William R Ringo, Director, sold 1,000 with an average share price of $49.37 per share and the total transaction amounting to $49,370.00.
- On 11/1/2017 William R Ringo, Director, sold 1,000 with an average share price of $29.55 per share and the total transaction amounting to $29,550.00.
Recent Trading Activity for NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB)
Shares of NASDAQ:ASMB – Assembly Biosciences closed the previous trading session at 39.88 down -4.40 9.94% with 43.790000915527344 shares trading hands.